Patient involvement is essential to offer quality oncology care and to advance oncology care research.
The digital patient self-reported symptoms enable regular evaluation of patient’s symptoms and condition and improve the efficiency and the quality of medical care.
The benefit of electronic tools (smart applications) is to promote the success of cancer therapy, to reduce the physical toxicity of therapy, to maintain the quality of life of the patient, within the family and in the society. Digital health increases patient’s communication with the treating physicians, within or outside the oncology team and structure and reduces the economic costs of cancer therapy.
The benefits of e-health and patients’ wishes are reflected in the written words by Paula Miller, February 2019. “It is very important to create an electronic file, a system for scheduling, organizing and archiving. When the disease progresses and at the same time the patient works, the organization of appointments, check-ups and medical results are absolutely necessary.
• create their medical history, which can share with their physician
• self-report their symptoms and share them with their physicians
• increase the success of therapy and maintain their quality of life
Live longer and better!
Oncologists and related professionals, involved in oncology care
• monitor their patients, are well informed on their symptoms and provide the appropriate, timely and effective treatment.
• reduce the complications and the economic costs of treatment
• increase the success of therapy
Maintain the quality of life for their patients!
Disease management in oncology patients under treatment using the digital tool CureCancer and appraisal of the quality of their lives.
Study for Master’s Diploma
Graduate Student: Chrysi Sopasi
Supervisor: Theoxaris Konstantinidis, Assistant Professor
Hellenic Mediterranean University - ELMETA, Crete, Greece, School of Health Sciences – Nursing Department – Graduate Studies Program “Advanced Clinical Practice on Health Sciences”
CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during covid-19 and reduces costs. A feasibility and satisfaction study.
ANNALS OF ONCOLOGY, VOLUME 31, Supplement 4, SEPTEMBER 1 2020.
The study is a collaboration of the Hellenic Society of Medical Oncologists - HeSMO, hesmo.gr, with CURECANCER.
It was agreed and signed during CURECANCER's hosting in the Incubator of Young Businesses, theathensincube.gr, of the Athens Chamber of Commerce and Industry - EBEA.
18 Clinical-Oncology Centers participated from all over Greece. The study was concluded on 15.12.2020. The study is currently being written up for publication.